Indication
Gynecological Malignancy
1 clinical trial
1 product
Product
RC48-ADCClinical trial
An Open, Multi-cohort, Multi-center Phase II Basket Clinical Study of RC48-ADC Monotherapy in the Treatment of HER2-expressing (HER2-positive and HER2 Low Expression) Gynecological MalignanciesStatus: Recruiting, Estimated PCD: 2024-10-01